Beijing SL Pharmaceutical Co., Ltd. (SHE:002038)
China · Delayed Price · Currency is CNY 6.52
+0.11 (1.72%)
Feb 4, 2026, 10:35 AM CST
Beijing SL Pharmaceutical Revenue
Beijing SL Pharmaceutical had revenue of 153.89M CNY in the quarter ending September 30, 2025, with 3.63% growth. This brings the company's revenue in the last twelve months to 578.61M, down -26.04% year-over-year. In the year 2024, Beijing SL Pharmaceutical had annual revenue of 660.42M, down -35.15%.
Revenue (ttm)
578.61M
Revenue Growth
-26.04%
P/S Ratio
11.38
Revenue / Employee
650.85K
Employees
889
Market Cap
6.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 660.42M | -357.94M | -35.15% |
| Dec 31, 2023 | 1.02B | -31.81M | -3.03% |
| Jan 1, 2023 | 1.05B | -164.65M | -13.55% |
| Jan 1, 2022 | 1.21B | 102.08M | 9.17% |
| Dec 31, 2020 | 1.11B | -916.97M | -45.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition